Related references
Note: Only part of the references are listed.Salmonella-mediated therapy targeting indoleamine 2, 3-dioxygenase 1 (IDO) activates innate immunity and mitigates colorectal cancer growth
Thuy Phan et al.
CANCER GENE THERAPY (2020)
Immunotherapy with immune checkpoint inhibitors in colorectal cancer: what is the future beyond deficient mismatch-repair tumours?
Nicolas Huyghe et al.
GASTROENTEROLOGY REPORT (2020)
Bouchardatine analogue alleviates non-alcoholic hepatic fatty liver disease/non-alcoholic steatohepatitis in high-fat fed mice by inhibiting ATP synthase activity
Yong Rao et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Host immune response to anti-cancer camptothecin conjugated cyclodextrin-based polymers
Yi-Fan Chen et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
Alyson Haslam et al.
JAMA NETWORK OPEN (2019)
Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
Wantong Song et al.
NATURE COMMUNICATIONS (2018)
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
Magalie Dosset et al.
ONCOIMMUNOLOGY (2018)
Characterization of the Selective lndoleamine 2,3-Dioxygenase-1 (IDO1) Catalytic Inhibitor EOS200271/PF-06840003 Supports IDO1 as a Critical Resistance Mechanism to PD-(L)1 Blockade Therapy
Bruno Gomes et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis
Wantong Song et al.
ADVANCED MATERIALS (2018)
RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
Wei Wang et al.
CANCER CELL (2018)
Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
Jianqin Lu et al.
NATURE COMMUNICATIONS (2017)
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Antoni Ribas et al.
CELL (2017)
The importance of hydrogen bonding in sphingomyelin's membrane interactions with co-lipids
J. Peter Slotte
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2016)
Emerging Opportunities and Challenges in Cancer Immunotherapy
Theresa L. Whiteside et al.
CLINICAL CANCER RESEARCH (2016)
MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade
Peter J. R. Ebert et al.
IMMUNITY (2016)
Expanding antigen-specific regulatory networks to treat autoimmunity
Xavier Clemente-Casares et al.
NATURE (2016)
The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin
Jianqin Lu et al.
BIOMATERIALS (2015)
A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models
Jayanta Bhattacharyya et al.
NATURE COMMUNICATIONS (2015)
Nanocarrier for Poorly Water-Soluble Anticancer Drugs-Barriers of Translation and Solutions
Mayuri Narvekar et al.
AAPS PHARMSCITECH (2014)
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
George C. Prendergast et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Magnetic resonance imaging with an iron oxide nanoparticle demonstrates the preclinical feasibility of predicting intratumoral uptake and activity of MM-398, a nanoliposomal irinotecan (nal-IRI)
Ashish V. Kalra et al.
CANCER RESEARCH (2014)
An improved D-α-tocopherol-based nanocarrier for targeted delivery of doxorubicin with reversal of multidrug resistance
Jianqin Lu et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Targeted Delivery of Doxorubicin by Folic Acid-Decorated Dual Functional Nanocarrier
Jianqin Lu et al.
MOLECULAR PHARMACEUTICS (2014)
Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR
Ulrike M. Litzenburger et al.
ONCOTARGET (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers
Jianqin Lu et al.
BIOMATERIALS (2013)
Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver
Yu Zhang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy (Review)
Yan-Jun Zhong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Glutathione levels in human tumors
Michael P. Gamcsik et al.
BIOMARKERS (2012)
IDO inhibits a tryptophan sufficiency signal that stimulates mTOR A novel IDO effector pathway targeted by D-1-methyl-tryptophan
Richard Metz et al.
ONCOIMMUNOLOGY (2012)
Tailor-Made Dual pH-Sensitive Polymer-Doxorubicin Nanoparticles for Efficient Anticancer Drug Delivery
Jin-Zhi Du et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel
Yong Zhang et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2010)
Ester Pyrolysis of Carbonates: Bis(benzene hydrate) Carbonate as Potential Precursor for Monomeric Carbonic Acid
Goetz Bucher
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2010)
[186Re]Liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model
Anuradha Soundararajan et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Loeb et al.
NATURE REVIEWS CANCER (2009)
Discovery and development of folic-acid-based receptor targeting for Imaging and therapy of cancer and inflammatory diseases
Philip S. Low et al.
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy
AJ Muller et al.
NATURE MEDICINE (2005)
Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness
N Jessani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models
A Gabizon et al.
JOURNAL OF DRUG TARGETING (2002)
Share Paper
